期刊文献+

原发皮肤结外鼻型NK/T细胞淋巴瘤一例

Primary cutaneous extranodal nasal type NK/T cell lymphoma:a case report
下载PDF
导出
摘要 47岁女性患者,皮肤多发性溃疡10个月,左面颊及右颈部包块6个月。皮损免疫组化染色示:CD3、颗粒酶B(Granzyme B)、LCA均阳性,Ki-67>75%阳性,CD56灶状阳性,CD30散在阳性,CD20阴性。原位杂交EBER阳性。乳酸脱氢酶7.0μmol/L,胸腹部CT检查提示脾脏受侵。超声多谱勒示:左颈部胸锁乳突肌、大鱼际肌及左侧颊部咬肌内局部肌纤维增粗,呈结节样改变。诊断:皮肤鼻型NK/T细胞淋巴瘤。给予VIPD方案化疗2周期,GDP方案化疗4周期;对部分溃疡行姑息性放疗。疗程结束后,原包块明显消退、溃疡愈合,原肌肉及脾脏受累基本消退,疗效评价为部分缓解。 A 47-year-old female patient presented with multiple skin ulcers for 10 months and masses on the left cheek and right neck for 6 months.Dermatological examination findings included palpable masses under the skin on the left cheek and right neck,and many sunken ulcers on the limbs.Immunohistochemistry staining showed that CD3,Granzyme B and LCA were all positive,Ki-67>75%positive,CD56 focally positive,CD30 scattered positive,CD20 negative;EBER was positive for in situ hybridization.LDH was 7.0μmol/L.CT examination of the chest and abdomen showed that the spleen was invaded.B-ultrasound showed that the local muscle fibers in sternocleidomastoid muscle,thenar muscle and masseter muscle of left cheek were thickened and with nodular formation.Diagnosis:cutaneous extranodal nasal NK/T cell lymphoma.The patients were treated with VIPD regimen chemotherapy for 2 cycles,GDP regimen chemotherapy for 4 cycles,and some ulcers were treated with palliative radiotherapy.After the course of treatment,the original masses subsided obviously,the ulcers healed,and the involvement of the muscle and spleen basically disappeared.The therapeutic effect was evaluated as partial relief.
作者 呼延卓雅 高红变 李索妮 郑琪 陆建荣 廖子君 HU YAN Zhuo-ya;GAO Hong-bian;LI Suo-ni(Department of Dermatology,Xi'an Medical University,Xi'an 710061,China)
出处 《实用皮肤病学杂志》 2020年第6期379-382,共4页 Journal of Practical Dermatology
关键词 淋巴瘤 NK/T细胞 Lymphoma NK/T cell
  • 相关文献

参考文献3

二级参考文献19

  • 1张之南,郝玉书,赵永强,等.血液病学[M].北京:人民卫生出版社,2011:1273.
  • 2Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-celllymphoma: a study of 136 cases from the International Peripheral T-CeU Lymphoma Project. Blood, 2009, 113 ( 17 ) : 3931-3937.
  • 3Suzuki R, Suzumiya J, Yamaguchi M, et al. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol, 2010, 21(5): 1032-1040.
  • 4Kim SJ, Kim K, Kim BS, et al. Phase trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage ] E to II E, nasal, extranedal NK/T-Cell lymphoma: Consortium for Improving Survival of Lymphoma study. J Clin Oncol, 2009, 27(35 ) : 6027-6032.
  • 5Yamaguchi M, Tobinai K, Oguchi M, et al. Phase I / II study of concurrent chemoradiotherapy for localized nasal natural killer/T- cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncal, 2009, 27(33):5594-5600.
  • 6Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for mali~ant lymphoma. J Clin Oncol, 2007, 25 (5) : 579- 586.
  • 7Yamaguchi M, Kwong YL, Kim WS, et al. Phase lI study of SMILEchemotherapy for newly diagnosed stage IV, relapsed, or refractory extranedal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol, 2011, 29 (33) : 4410-4416.
  • 8Jaccard A, Gachard N, Marin B, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood, 2011, 117(6) : 1834-1839.
  • 9Zinzani PL, Venturini F, Stefoni V,et al. Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. Ann Oncol, 2010, 21 (4) : 860-863.
  • 10Kohrt H, Advani R. Extranodal natural killer/T-cell lymphoma: cur- rent concepts in biology and treatment[ J]. Leuk Lymphoma,2009, 50 ( 11 ) : 1773 - 1784.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部